A higher level of diabetes care.

Automated, integrated, convenient teleretinal solution.

Screen early

Manage better

Complete quality measures

Scan early.

Close the gap in diabetes care.

The VELARA™ Teleretinal Screening System from ZEISS is a complete solution for retinal screening that facilitates early detection and treatment of diabetic eye disease—all within the convenience of your primary care setting.

Learn how you can optimize your practice workflow and help close the care gap for patients diagnosed with diabetes.

Simplicity in the palm of your hand.

Intuitive and easy-to-operate, the ZEISS VELARA 200 fundus camera automatically aligns and focuses, enabling your staff to capture high-quality images of the patient’s retina.

Fast and secure access—from anywhere, at any time.

Board-certified eye care providers can quickly and confidently analyze patient images using the VELARA cloud-based platform and grading application.

Seamless integration improving the continuum of care.

ZEISS VELARA integration software creates and returns the diagnostic report to your patient’s electronic medical record (EMR) for immediate billing, consultation and treatment.

The built-in connectivity with ZEISS FORUM®, makes it easy for you to share data with your patient’s eye care specialist.

Manage better.

Improve workflow efficiency.

With ZEISS VELARA you can provide complete, connected care to your patients in one clinic visit with results delivered in as little as one day.

Streamlining the patient and provider experience.

From image capture to follow-up, ZEISS VELARA saves time, minimizes errors, and promotes better, long-term care for your patients.

Capture: retinal images taken as part of routine exam

Upload: images stored on secure, cloud-based platform

Enhance: algorithm ensures high-quality gradability

Diagnose: images graded by licensed eye care provider

Consult and refer: diagnostic report automatically added to patient’s EMR

Follow-up: data shared with patient’s eye care specialist for on-going treatment

Complete quality measures.

Retinal screening at the point of care.

HEDIS is one of the health care industry’s most widely used performance improvement tools. When you provide retinal screening at the point of care, you can immediately fulfill the HEDIS requirement for Complete Diabetic Care (CDC) and receive a Risk Adjustment Factor (RAF) eligible diagnosis—improving your quality metrics and reimbursement.

A comprehensive approach to routine retinal screening in the primary care practice.

John Doe, MD World-Class Clinic, Earth

Axim nonseque autem. Moluptate vel iducitium nonsed ende vitiur ati il ma di qui volessi tibusapident exerro ipsae pore quiae por millantent harchillam voluptae perferio est.

Share this page:

Cost-effective, worry-free service and support.

The VELARA Teleretinal Screening System from ZEISS is a subscription-based solution that includes the system hardware, software, EMR integration, service, support and any required training—no separate maintenance agreements or future upgrades to purchase.

Plus, you can tailor the subscription to fit your needs. You can elect to pay yearly, quarterly, monthly or prepay depending on your budget.

Unable to load form.


ZEISS VELARA - A higher level of diabetes care EN
pages: 7
file size: 6000 kB


Make a sales request

For sales inquiries and general questions and comments.

Contact us directly

+1 (800) 442-4020

Service & Support

For technical assistance with your ZEISS equipment.